Is Vision Eye Institute Ltd a takeover target?

Could Vision Eye Institute Ltd (ASX:VEI) won a big court case recently.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Vision Eye Institute Ltd (ASX: VEI) has announced that it will received almost $11 million in damages and interest from eye doctor, Dr David Kitchen, following a favourable Queensland Supreme Court decision.

So What: Vision Eye Institute is an Australian-based provider of ophthalmic care, providing various treatments for people suffering eye disorders and diseases. The damages to be received relate to what Vision Eye Institute contended was Dr Kitchen's wrongful termination of his service agreement with one of its subsidiaries, Icon Laser Australia, back in 2009.

His departure from the business, together with Vision Eye's inability to find a replacement (due to the shortage of eye doctors in the region), forced it to close its facility in Rockhampton which impacted the company's financial results at the time.

While Dr Kitchen will have four weeks to appeal the decision, Honourable Justice Applegarth has ordered him to pay Vision Eye Institute a total of $10,845,476.

Now What: Although the company's recent earnings results have proven quite underwhelming, the Vision Eye Institute could certainly be one to watch.

To begin with, the company could stand to benefit from Australia's ageing population (should that result in greater demand for eye care), while it could also become a takeover target for Primary Health Care Limited (ASX: PRY) which, as at 8 August 2014, owned almost 22% of the business.

Motley Fool contributor Ryan Newman does not own shares in any of the companies mentioned. You can follow Ryan on Twitter @ASXvalueinvest. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »